146 related articles for article (PubMed ID: 16278981)
1. Cancer protection.
Harv Health Lett; 2005 Oct; 30(12):7. PubMed ID: 16278981
[No Abstract] [Full Text] [Related]
2. Metformin OK in CKD?
Drug Ther Bull; 2014 Apr; 52(4):37. PubMed ID: 24698854
[No Abstract] [Full Text] [Related]
3. Metformin: a multitasking medication.
Bailey CJ
Diab Vasc Dis Res; 2008 Sep; 5(3):156. PubMed ID: 18777487
[No Abstract] [Full Text] [Related]
4. Metformin: an alternative treatment for noninsulin-dependent diabetes mellitus.
Hitt CM
Conn Med; 1995 Dec; 59(12):727-30. PubMed ID: 8821636
[No Abstract] [Full Text] [Related]
5. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
6. [Vitamin B12 deficiency in diabetic patients taking metformin].
Mariño Suárez JE; Izquierdo Pradas L; Milán Vegas A
Med Clin (Barc); 2012 Apr; 138(11):499-500. PubMed ID: 22014847
[No Abstract] [Full Text] [Related]
7. Metformin in type 2 diabetes.
Fox GN
J Fam Pract; 2004 Nov; 53(11):900. PubMed ID: 15527727
[No Abstract] [Full Text] [Related]
8. Metformin-associated lactic acidosis in a patient with vertebral artery dissection.
Packer CD
South Med J; 2006 Oct; 99(10):1147-8. PubMed ID: 17100045
[No Abstract] [Full Text] [Related]
9. Metformin and cancer: licence to heal?
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Investig Drugs; 2010 Aug; 19(8):913-7. PubMed ID: 20557275
[TBL] [Abstract][Full Text] [Related]
10. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
Almirall J; Bricullé M; Gonzalez-Clemente JM
Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
[No Abstract] [Full Text] [Related]
11. [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
Neye H
Pharm Unserer Zeit; 2002; 31(3):264-70. PubMed ID: 12071123
[No Abstract] [Full Text] [Related]
12. Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
[No Abstract] [Full Text] [Related]
13. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
Wildasin EM; Skaar DJ; Kirchain WR; Hulse M
Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
15. Is it time to test metformin in breast cancer prevention trials? A reply to the authors.
Barba M; Muti P
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2565; author reply 2565. PubMed ID: 19745224
[No Abstract] [Full Text] [Related]
16. Erythema multiforme from metformin.
Burger DE; Goyal S
Ann Pharmacother; 2004 Sep; 38(9):1537. PubMed ID: 15226487
[No Abstract] [Full Text] [Related]
17. Sitagliptin/metformin (Janumet) for type 2 diabetes.
Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
[No Abstract] [Full Text] [Related]
18. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
[TBL] [Abstract][Full Text] [Related]
19. Metformin-induced pseudoporphyria.
Lenfestey A; Friedmann D; Burke WA
J Drugs Dermatol; 2012 Nov; 11(11):1272. PubMed ID: 23135074
[No Abstract] [Full Text] [Related]
20. [Metformin is also recommended in mild and moderate renal failure].
Zechmann S
Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
